abstract |
The present invention relates to a class of compounds represented by formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of Formula (I), and methods of selectively antagonizing the ανβ 3 and/or the ανβ 5 integrin without significantly antagonizing the IIb/IIIa integrin. |